Şahin ÇOLAK, Mehmet Özgür ERDOĞAN, Ahmet BAYDIN, Mustafa Ahmet AFACAN, Celal KATI, Latif DURAN

Epidemiology of organophosphate intoxication and predictors of intermediate syndrome

To evaluate the usefulness of plasma glucose and serum cholinesterase levels as predictors of organophosphate-induced intermediate syndrome. Materials and methods: Seventy-one organophosphate poisoning patients who were admitted to our emergency department during a 4-year period were evaluated retrospectively. Four patients were excluded from the study due to a lack of medical records. Categorical variables were analyzed using the chi-square test and nonparametric variables were analyzed using the Mann-Whitney U test. Results: Thirty-five (52.2%) patients were male and 32(47.8%) were female. Patients had a mean age of 39.4 ± 15.9 years and 70.1% of the patients were married. Oral intake (68.7%) was the most common method of intoxication, and attempted suicide (67.2%) was the most common cause. The most common organophosphates were methamidophos (20.8%), dichlorvos (19.4%), parathion (7.5%), and methyl parathion (7.5%). Fifty-seven (85%) patients were treated in the emergency observation unit and 10 (15%) patients were admitted to the intensive care unit. Eleven (16%) patients developed intermediate syndrome and had significantly lower levels of serum cholinesterase (P < 0.01) and higher blood glucose levels (P = 0.037). Conclusion: Initial serum cholinesterase and glucose levels measured in the emergency department may be a useful marker in predicting organophosphate-induced intermediate syndrome.

Anahtar Kelimeler:

Key words: Intoxication, organophosphate, hyperglycemia, intermediate syndrome, cholinesterase

Epidemiology of organophosphate intoxication and predictors of intermediate syndrome

Keywords:

Key words: Intoxication, organophosphate, hyperglycemia, intermediate syndrome, cholinesterase,

PDF

___

Sogorb MA, Vilanova E, Carrera V. Future applications of phosphotriesterases in the prophylaxis and treatment of organophosphorus insecticide and nerve agent poisonings. Toxicol Lett 2004; 151: 219–33.
Langley R, Sumner D. Pesticide mortality in the United States, 1979–1998. Vet Hum Toxicol 2002; 44: 101–5.
Öztürk MA, Keleştimur F, Kurtoğlu S, Güven K, Arslan D. Anticholinesterase poisoning in Turkey--clinical, laboratory and radiologic evaluation of 269 cases. Hum Exp Toxicol 1990; 9: 273–9.
Sudakin DL, Mullins ME, Horowitz BZ, Abshier V, Letzig L. Intermediate syndrome after malathion ingestion despite continuous infusion of pralidoxime. J Toxicol Clin Toxicol 2000; 38: 47–50.
Senanayake N, Karalliedde L. Neurotoxic effects of organophosphorus insecticides: an intermediate syndrome. New Engl J Med 1987; 316: 761–3.
Karalliedde L. Organophosphorus poisoning and anaesthesia. Anaesthesia 1999; 54: 1073–88.
Karalliedde L, Senanayake N. Organophosphorus insecticide poisoning. Br J Anesth 1989; 63: 736–50.
Nouira S, Abroug F, Elatrous S. Prognostic value of serum cholinesterase in organophosphate poisoning. Chest 1994; 106: 1811–14.
Yang CC, Deng JF. Intermediate syndrome following organophosphate insecticide poisoning. Chin Med Assoc 2007; 70: 467–72.
Abdollahi M, Karami-Mohajeri S. A comprehensive review on experimental and clinical ﬁndings in intermediate syndrome caused by organophosphate poisoning. Toxicol Appl Pharmacol 2012; 258: 309–14.
Dippenaar R, Diedericks RJ. Paediatric organophosphate poisoning – a rural hospital experience. S Afr Med J 2000; 95: 678–81.
Emerson GM, Gray NM, Jelinek GA, Mountain D, Mead HJ. Organophosphate poisoning in Perth, Western Australia, 1987–1996. J Emerg Med 1996; 17: 273–7.
Levy-Khademi L, Tenenbaum AN, Wexler ID, Amitai Y. Unintentional organophosphate intoxication in children. Pediatr Emerg Care 2007; 23: 716–8.
Yurumez Y, Yavuz Y, Saglam H, Durukan P, Ozkan S, Akdur O, Yücel M. Electrocardiographic findings of acute organophosphate poisoning. J Emerg Med 2009; 36: 39–42.
Pajoumand A, Shadnia S, Rezaie A, Abdi M, Abdollahi M. Benefits of magnesium sulfate in the management of acute human poisoning by organophosphorus insecticides. Hum Exp Toxicol 2004; 23: 565–9.
Stallones L, Beseler C. Pesticide poisoning and depressive symptoms among farm residents. Ann Epidemiol 2002; 12: 389–94.
Yurumez Y, Durukan P, Yavuz Y, Ikizceli I, Avsarogullari L, Ozkan S, Akdur O, Ozdemir C. Acute organophosphate poisoning in university hospital emergency room patients. Intern Med 2007; 46: 965–9.
Saadeh AM, al-Ali MK, Farsakh NA, Ghani MA. Clinical and sociodemographic features of acute carbamate and organophosphate poisoning: a study of 70 adult patients in north Jordan. J Toxicol Clin Toxicol 1996; 34: 45–51.
Şahin HA, Şahin İ, Arabacı F. Sociodemographic factors in organophosphate poisonings; a prospective study. Hum Exp Toxicol 2003; 22: 349–53.
Agarwal SB. A clinical, biochemical, neurobehavioral, and socio psychological study of 190 patients admitted to hospital as a result of acute organophosphorus poisoning. Environ Res 1993; 62: 63–70.
Ozer C, Kuvandik G, Gokel Y, Duru M, Helvaci MR. Clinical presentation and laboratory findings of organic phosphorus poisoning. Adv Ther 2007; 24: 1321–9.
Rivera JA, Rivera M. Organophosphate poisoning. Bol Asoc Med P R 1990; 82: 419–22.
Sahin I, Onbasi K, Sahin H, Karakaya C, Ustun Y, Noyan T. The prevalence of pancreatitis in organophosphate poisonings. Hum Exp Toxicol 2002; 21: 175–7.
Brahmi N, Mokline A, Kouraichi N, Ghorbel H, Blel Y, Thabet H, Hedhili A, Amamou M. Prognostic value of human erythrocyte acetyl cholinesterase in acute organophosphate poisoning. Am J Emerg Med 2006; 24: 822–7.
Kara IH, Güloğlu C, Karabulut A, Orak M. Sociodemographic, clinical, and laboratory features of cases of organic phosphorus intoxication who attended the Emergency Department in the Southeast Anatolian Region of Turkey. Environ Res 2002; 88: 82–
Teixeira H, Proença P, Alvarenga M, Oliveira M, Marques EP, Vieira DN. Pesticide intoxications in the Centre of Portugal: three years analysis. Forensic Sci Int 2004; 143: 199–204.
Yamashita M, Tanaka J, Ando Y. Human mortality in organophosphate poisoning. Vet Human Toxicol 1997; 39: 84–
Clark RF. Insecticides: Organic phosphorus compounds and carbamates. In: Goldfrank LR, Flomenbaum NE, Lewin NA, Nelson LS, editors. Goldfrank’s Toxicologic Emergencies. 8th ed. Stamford, CT, USA: Appleton & Lange; 2006. pp. 1497–512.
Tsai JR, Sheu CC, Cheng MH, Hung JY, Wang CS, Chong IW, Huang MS, Hwang JJ. Organophosphate poisoning: 10 years of experience in southern Taiwan. Kaohsiung J Med Sci 2007; 23: 112–
Avasthi G, Singh G. Serial neuro-electrophysiological studies in acute organophosphate poisoning--correlation with clinical findings, serum cholinesterase levels and atropine dosages. J Assoc Physicians India 2000; 48: 794–9.
He F, Xu H, Qin F, Xu L, Huang J, He X. Intermediate myasthenia syndrome following acute organophosphates poisoning-an analysis of 21 cases. Hum Exp Toxicol 1998; 17: 40–
Al B, Güllü MN, Küçüköner M, Aldemir M, Güloğlu C. Demographic features of patients resorted to the dicle university medicine faculty emergency service with organophosphate intoxication. Tıp Araştırmaları Dergisi 2006; 4: 5–13 (in Turkish with abstract in English).
Aygun D, Erenler AK, Karatas AD, Baydin A. Intermediate syndrome following acute organophosphate poisoning: correlation with initial serum levels of muscle enzymes. Basic Clin Pharmacol Toxicol 2007; 100: 201–4.
Fahy BG, Sheehy AM, Coursin DB. Glucose control in the intensive care unit. Crit Care Med 2009; 37: 1769–76.